NDC 54771-7521 - Quest Plus
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54771-7521
- Package NDCs from labels
- 54771-7521-1
- Manufacturer
- Zoetis Inc.
- Effective date
- 2021-01-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| QUEST ® PLUS GEL (moxidectin/praziquantel) | Zoetis Inc. | 2021-01-05 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54771-7521-1 | Quest Plus | 11.6 g in 1 SYRINGE | GEL | 11.6 | 5 | |
| 54771-7521-1 | Quest Plus | 1 in 1 CARTON | GEL | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54771-7521 | QUEST PLUS (MOXIDECTIN AND PRAZIQUANTEL) GEL [ZOETIS INC.] | 5 | 2 package rows | 20210106_5ebc9173-18cf-425e-8e37-69a1715bd9af.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| moxidectin | ACTIVE INGREDIENT | NGU5H31YO9 | QUEST PLUS (MOXIDECTIN AND PRAZIQUANTEL) GEL [ZOETIS INC.] | 1 | |
| praziquantel | ACTIVE INGREDIENT | 6490C9U457 | QUEST PLUS (MOXIDECTIN AND PRAZIQUANTEL) GEL [ZOETIS INC.] | 1 | |
| moxidectin | ACTIVE MOIETY | NGU5H31YO9 | QUEST PLUS (MOXIDECTIN AND PRAZIQUANTEL) GEL [ZOETIS INC.] | 1 | |
| praziquantel | ACTIVE MOIETY | 6490C9U457 | QUEST PLUS (MOXIDECTIN AND PRAZIQUANTEL) GEL [ZOETIS INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PRAZIQUANTEL | PRAZIQUANTEL | Par Health USA, LLC | 16f2b9c4-a260-4a31-bd52-e5945913246c | 2026-08-12 | Warnings, Adverse reactions | 6490C9U457 |
| Moxidectin | MOXIDECTIN | Medicines Development for Global Health | 6eb02ae9-9065-176f-e053-2991aa0ac891 | 2026-07-30 | Warnings, Adverse reactions | NGU5H31YO9 |
| Biltricide | PRAZIQUANTEL | Bayer HealthCare Pharmaceuticals Inc. | 34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9 | 2026-03-02 | Warnings, Adverse reactions | 6490C9U457 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.